1. Short title This Act may be cited as the National Commission on COVID-19 Act . 2. Establishment of Commission There is established in the legislative branch the National Commission on COVID-19 in the United States (hereinafter in this Act referred to as the Commission ). 3. Purposes (a) In general The purposes of the Commission are to— (1) examine the facts and circumstances relating to the emergence and spread in the United States of the respiratory illness known as coronavirus disease 2019 (hereinafter in this Act referred to as COVID-19 ); (2) evaluate the United States preparation for and response to COVID-19; and (3) report to the President and Congress on its findings, conclusions, and recommendations for corrective measures that can be taken to prevent, prepare for, respond to, and mitigate the effects of future pandemics in the United States. (b) Particular subjects for review In particular, the Commission shall examine, evaluate, make findings and recommendations, and report on the United States preparation for and response to COVID-19 as it relates to— (1) surveillance, testing, treatments, and vaccines; (2) personal protective equipment for health workers and other first responders; (3) medical devices, equipment, drugs, and supply chains; (4) the use and public health impact of social distancing practices, stay-at-home directives, school and business closures, and other measures prescribed by government authorities or adopted voluntarily in order to contain the virus; (5) the preparedness and capacity of the United States health care system, including hospitals, physicians, community health centers, and laboratories; (6) the Federal Government’s actions, including guidance, regarding altered standards of care, end of life care, and prioritization of scarce medical and emergency resources; (7) the National Response Framework and any other applicable response plans; (8) the Defense Production Act; (9) the Strategic National Stockpile